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g.2012.0Abstract This unreeled study aimed to examine the relationship between the genetic polymor-
phisms C677T in MTHFR gene and mapped this ﬁgure with other ethnic populations. The present
study examined 70 Saudi females (30 mothers with DS children plus 40 healthy mothers who gave
birth only to healthy children) for C677T genotypes using restriction fragment length polymor-
phism (RFLP) of the ampliﬁed genomic DNA. The frequencies of the combined mutant genotypes
CT and TT in the MTHFR gene were modestly represented in the case mothers compared to that in
controls (33% vs. 35% and 13% vs. 10%) with no signiﬁcance (OR 1.1, 95% CI, 0.41–2.77,
p= 0.91). The frequency of the mutant 677T allele was 28% in the case mothers and plotted as
a moderate value with different ethnic populations. The present study concluded that there was a
null association between the common C677T polymorphism and the increased risk of Down syn-
drome, but the T allele slightly supported the increase of this maternal risk. The intermediacy to
previous reports may probably be due to the small sample size, gene-nutritional-environmental fac-
tors, or the consequences of much social intermarriage between some Asian, Arab peoples and the
Saudi community.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.le: +966 55 550 2250.
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4.0031. Introduction
Down syndrome (DS) or trisomy 21 is a genetic disease caused
by abnormal chromosomal segregation [1]. Free trisomy 21 is
found in 95% of DS cases and is due to chromosome 21 non-
disjunction, mostly occurring during maternal meiosis [2]. A
mechanism to explain chromosomal non-disjunction has been
proposed and consists of defects in DNA methylation with
consequent centromeric hypomethylation, causing abnormal
kinetochore and microtubule formation [3–6]. A number of
genetic and environmental factors have been suggested to play
interactively a role in aneuploidization, among which dietaryier B.V. All rights reserved.
264 M.T. Tayebfactors [7]. Folate acid (pteroiloglutamic acid) has an impor-
tant role in the process of genetic material distribution during
cell division, because of its part in the cellular methylation
reactions, which, in turn, epigenetically regulate segregation
and other processes [8].
Recent evidence shows that almost 92% of the DS children
are born from young mothers, suggesting that other risk factors
than advanced maternal age must be involved. Within this con-
text, some studies suggested and even demonstrated a possible
link betweenDS andmaternal polymorphisms in genes involved
in folate metabolism [9,10]. Methylenetetrahydrofolate reduc-
tase (MTHFR) has a crucial role in regulating cellular methyla-
tion, through the conversion of 5,10-methyltetrahydrofolate
(THF) to 5-methyl THF, the methyl donor in the transforma-
tion of homocysteine to methionine [11]. The C–T common
polymorphism at nucleotide 677 (C677T), which results into
an alanine to valine substitution in theMTHFR protein, causes
higher thermolability and reduced enzyme activity in lympho-
cyte extracts [12]. Increased folic acid intake is required tomain-
tain homocysteine remethylation tomethionine at normal levels
[13]. Reduced MTHFR activity due to the C677T change has
been associated with different disorders, including vascular
diseases [12], neural tube defects [14–16], male infertility [17],
Alzheimer’s [18], and Parkinson diseases [19]. The C677T poly-
morphism has been related also tomaternal risk forDS, because
of a higher prevalence of the T allele among mothers of children
with trisomy 21, compared to control mothers [9,10]. The iden-
tiﬁcation of the C677T as a factor of maternal risk for DSmight
be of great importance in the genetic counseling of this disease,
since in this case other female relatives of a carrier DS mother
should be tested for the presence of this mutation. Here, this
study investigated the prevalence of the C677T polymorphism
in a sample of Saudi mothers of DS children.
2. Subjects and methods
2.1. Study population
The present study includes 70 women (ages 18–45 years old):
30 of them, that gave birth to DS children; cytogenetically con-
ﬁrmed as regular trisomy 21. The average ages ± SD of case
mothers was 31.7 ± 7.5 years. The 40 controls were mothers
who gave birth only to healthy children, without any history
of miscarriages or abnormal pregnancies. All women in this
study live in the same geographic area (Western region of
Saudi Arabia). Informed consent was obtained from all the
participants. There was no periconceptional use of folic acid.
2.2. DNA extraction
Peripheral blood samples were collected on EDTA from both
DS and control mothers. Genomic DNA was isolated from
whole blood (0.2 ml), using QIAamp DNA Blood kit (Qiagen,
Hilden, GmbH, Germany) as recommended by the manufac-
turer’s instructions.
2.3. Genotyping of MTHFR gene
To identify the MTHFR 677C > T polymorphism, genomic
DNA was ampliﬁed by polymerase chain reaction (PCR) usingspeciﬁc primers sequences of MTHFR gene; 50-TGA AGG
AGA AGG TGT CTG CGG GA-30 and 50-AGG ACG
GTG CGG TCA GAG TG-30 [12]. A mixture of 25-ll reaction
volume of 0.5 lM of each primer, 200 lM of each dNTP,
67 mg Tris–HCl, 16 mM (NH4)2SO4, 0.01% Tween-20,
1 mM MgCl2 and 0.15 units Taq DNA polymerase. The
samples were then subjected to 35 cycles on PCR Engine Dyad
(Bio-Rad Laboratories, USA) with annealing at 58 C for 30 s.
The PCR product was incubated overnight with the HinfI
enzyme at 37 C for complete digestion, and the fragments
were separated on 3% MetaPhor agarose gel (BMA,
Rockland, ME, USA). The product was then identiﬁed by
ethidium bromide staining and photographed using a gel-
documentation system (G-Box, SynGene, Frederick, MD,
USA). The absence of HinfI recognition site revealed a 198-
bp fragment due to the homozygous wild-type 677C/C geno-
type, while the presence of the HinfI cutting site due to the
homozygous mutant 677T/T genotype gave the 175-bp main
fragment. The 677C/T heterozygous status is expressed as
two fragments of 175-bp and 198-bp sizes.
2.4. Data analysis
Statistical analysis was performed using the SPSS 16.0 (SPSS,
Chicago, IL, USA). The data are presented as mean ± stan-
dard deviation (SD). Nonparametric measures were used to
calculate chi-square values. A probability <0.05 was consid-
ered statistically signiﬁcant. Odds ratios with 95% conﬁdence
intervals were calculated.
3. Results
In the mothers of DS children, the C/C wild homozygous
genotype was found in 53.3%, the C/T heterozygous genotype
in 33.3% and the T/T mutant homozygous genotype in 13.3%
(Table 1). In the control mothers, the C/C genotype frequency
was 55%, C/T 35% and T/T 10%. There were no signiﬁcant
differences in genotype frequencies between the two groups
(OR 1.1, 95% CI, 0.41–2.77, p= 0.91). Overall, the frequency
percentage of the C allele was 70% in DS mothers and 73% in
control mothers. There was no difference in the prevalence of
the MTHFR variant T allele in the same groups (30.5% and
31.25%, respectively).
4. Discussion
Progressions have been achieved to clarify the important role
of the MTHFR enzyme in metabolic pathway of folate and
nucleotide methylation. Presence of 677T allele leads to reduc-
tion of MTHFR activity and DNA hypomethylation. It has
been understood that hypomethylation of DNA has been re-
lated to chromosomal changes and instability. Studies on the
role of polymorphisms in folate metabolism as a risk factor
for DS have obtained controversial results [13,20]. Most of
these studies have investigated polymorphisms in the MTHFR
gene.
The hypothetical effect of 677T onto maternal non-
disjunction was linked to an altered DNA methylation pattern
on the oocyte, secondary to reduced MTHFR activity.
Hassold et al. [21] analyzed maternal polymorphism at
Table 2 Distribution of a common C677T MTHFR polymorphism among different ethnic populations.
Population Total subjects Heterozygous, C/T n (%) Homozygous mutant, T/T T allele frequency (%) References
Australia 85 8 (9.4) 0 (0.0) 4.7 [33]
Africaa,b 301 38 (12.6) 0 (0.0) 6.3 [36]
US Blacksb 496 127 (25.6) 6 (1.2) 14.0 [36]
Middle east
Egypt 48 12 (25) 3 (6.2) 18.8 [26]
Yemen 46 14 (30.4) 1 (2.2) 17.4 [33]
Saudi Arabia 40 14 (35) 4 (10) 28 Present study
Turkey 93 39 (41.9) 7 (7.5) 28.5 [37]
Asiac 279 92 (33.0) 12 (4.3) 20.8 [33]
US Whitesb 1147 512 (44.6) 136 (11.9) 34.2 [36]
Japanb 2472 1171 (47.4) 284 (11.5) 35.2 [36]
Britainb 1046 465 (44.5) 138 (13.2) 35.4 [36]
Canada (Quebec)b 414 183 (44.2) 59 (14.3) 36.3 [36]
a Including Sub-Saharan Africa, Zaire, Cameroon.
b Pooled data.
c Including Hong Kong, Mongolia, Indones.
Figure 1 Frequency of 677T mutant allele in mothers with DS children in comparison with that in different populations.
Table 1 The distribution of MTHFR genotype and allele frequencies in case and control population.
Population n Genotype distribution (%) Allele frequency
C/C C/T T/T C T
Case 30 16 (53.3) 10 (33.3) 4 (13.3) 0.70 0.30
Control 40 22 (55.0) 14 (35.0) 4 (10.0) 0.73 0.28
MTHFR gene and maternal risk with Down syndrome 265MTHFR in cases of trisomies of other chromosomes, detecting
signiﬁcant association only with trisomy 18. Reports of the
677C > T nucleotide substitution in relation to oral clefts,
Down syndrome, and fetal anticonvulsant syndrome either
have yielded conﬂicting results or have not been yet replicated
[22–24].
To the best of our knowledge, this is the ﬁrst study that
investigated the prevalence of MTHFR C677T alleles and
genotype distribution in the Saudi females. Data obtained in
our study does support a little increase of DS mothers with
the 677T allele compared to controls in Saudi samples (Table
1). The C/T or T/T genotypes results do not rule out an effect
of the 677T allele on maternal non-disjunction, but were nearly
being equal in both controls and mothers with DS children. Thepresent study suggests that in populations with adequate folate
dietary intake the reduced enzymatic activity of the MTHFR in
the carriers of the T allele is balanced by folates, thus reducing
the risk of cellular demethylation and non-disjunction.
It is a point of interest since the genotypes in the mothers of
DS children were comparable to those reported in Table 2,
while controls disclosed a lower frequency of the T allele
(0.28), and the C/T and T/T genotypes accounting for 46%
of the analyzed controls. The difference between case and
controls was not signiﬁcant (p> 0.05). These data conﬁrm
previous studies by showing a lower prevalence of the T allele
in the Saudi population [9,10,25–27].
The distribution of 677T allele indicated that the rate of
combined mutant 677 (C/T + T/T) genotypes reported mod-
Table 3 Prevalence of the 677C/T MTHFR genotypes in DS mothers and controls.
Population (references) Cases controls DS mothers Controls
CC (%) CT (%) TT (%) CT + TT (%) CC (%) CT (%) TT (%) CT+ TT (%)
This study 30 53 33 13 46 55 35 10 45
(Saudi Arabia) 40
Egypt [26] 42 47.6 40.5 11.9 52.4 68.8 25 6.2 31.2
48
South India [32] 36 91.7 8.3 0 3 60 0 0 0
60
Irish [28] 48 44 51 5 56 47 44 9 53
192
Italy [25] 64 31 50.7 18.3 69 24.1 55.4 20.5 75.9
112
Danish [23] 177 52 40.7 7.3 85 50.3 41.4 8.3 49.7
1084
North America [10] 157 32 54 14 68 48 42 10 52
77
Canada [9] 57 26 60 14 74 48 44 8 52
50
Brazil [30] 154 43.5 46.8 9.7 56.5 53.2 42.4 4.4 46.8
158
Figure 2 The heterozygous, homozygous mutants and T allele frequencies at position 677 of MTHFR gene in different populations and
present study.
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(Fig. 1). Several reports reviewed in Table 2 imply that the T
allele frequency are substantially lower in our cases compared
to that of North American, Canadian, Irish and Italian popu-
lations [9,10,25,28]. The Egyptian report of Meguid et al. [26]
and Shawky et al. [27] might closely agree our genotypic data.
Acacio et al. [29] found that the frequency of joint heterozyg-
otic polymorphism 677C/T of MTHFR gene was signiﬁcantly
higher in 70 Brazilian DS females, but in contrast da Silva
et al. [31] showed it was near borderline signiﬁcance among
154 Brazilian DS females (p= 0.08) (Table 3). In an study
from India, where 677T allele frequency is quite low in the
population Rai et al. [31] have shown a strong association of
this SNP, especially the T homozygote, with <30 year-DSmothers. Interestingly, the T homozygous case mothers were
all younger than 30 years of age. In this regard, Fig. 1 dis-
played the two extremes of the T allele frequency in both Dan-
ish and Indian populations [23,32].
The ethnic population frequency of C677T homozygosity
ranges from 1% or less among Blacks from Africa and the
United States to 20% or more among Italians and US Hispan-
ics [33]. The CT, TT and T allele frequencies in Saudi mothers
with DS children were compared with different populations
(Table 2 and Fig. 2).
The issue of the intermediacy of our outcomes in Saudi fe-
males in comparison with other ethnic populations might be
reasonably subjected to (1) the hypothesis that the interaction
between different polymorphisms within the human genome
MTHFR gene and maternal risk with Down syndrome 267may totally modify their individual effects [34], (2) the conse-
quences of much social intermarriage with some Asian, Arab
people and the Saudi community toughened the heterogeneity,
the pleiotropy, and variable expressivity of the disease [35],
and (3) the adequate folate dietary intake reduces the enzy-
matic activity of the MTHFR in the individuals with the
677T allele, thus reducing the risk of cellular demethylation
and non-disjunction.
In conclusion, though conﬂictions have been come up
among different ethnic populations, here, the unreeled study
described null association between the C677T genetic variant
and the mothers with DS children among the Saudi commu-
nity. This ﬁnding does support a modest risk increase of the
T allele in the cases compared to controls. Our observations
were in agreement with other ethnic populations, but sustain
the need for replication of a cohort study of the 677C > T
polymorphism among DS mothers.Acknowledgments
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